Infliximab Therapy Leading to Pulmonary Tuberculosis in a Patient With Negative Interferon γ Release Assay (IGRA)-Based QuantiFERON Gold Test

Infliximab therapy is associated with higher rates of active tuberculosis (TB), particularly extrapulmonary and disseminated forms with unusual symptoms. We report the case of a 66-year-old man with Crohn’s disease who developed TB mimicking lung cancer on imaging. He presented with cough and fever...

Descripción completa

Detalles Bibliográficos
Autores principales: Parita, Soni, Vivek, Kumar, Stephan, Kamholz, William, Pascal, Yizhak, Kupfer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507378/
https://www.ncbi.nlm.nih.gov/pubmed/28748193
http://dx.doi.org/10.1177/2324709617717540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507378/
https://www.ncbi.nlm.nih.gov/pubmed/28748193
http://dx.doi.org/10.1177/2324709617717540

Ejemplares similares